BioSpace News Archive

Theralase announced today that it has executed a Sponsored Research Agreement (“SRA”) with the University of Manitoba (“UM”) Medical Microbiology department to commence development of a coronavirus vaccine and therapy utilizing Theralase’s patented and proprietary PDCs.

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) (“MediPharm Labs” or the “Company”) a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, today announced that its Australian operation – MediPharm Labs Australia Pty. Ltd.

Harbour BioMed (HBM), and its partners Utrecht University and Erasmus Medical Center, today announced a new research collaboration with Viroclinics-DDL and Kiadis Pharma (Euronext Amsterdam and Brussels: KDS) that will focus on the development of a combination of a monoclonal anti

ZYUS Life Sciences Inc. (“ZYUS”), a next-generation life sciences company leading scientific research and development in phyto-therapeutics, announced today that it has strengthened its leadership team with the appointm

Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the second quarter ended June 30, 2020. Financial Highlights Second Quarter 2020 vs. First Quarter 2020 Revenues of $13.6 million, an increase of $6.1 million or 82%, stronger demand for both US topical products and injectable products sold in Canada Gross profit of $2.5 million, an increase of $3.7 mill

Bio-Techne Corporation (NASDAQ:TECH), in partnership with Leica Biosystems, today announced the automation of RNAscope™ COVID-19 probes on BOND RX*, Leica’s staining platform, for research use only. Researchers now have the a

Verndari, Inc. Announces Publication in the Journal Vaccine of Early Data Using VaxiPatch ™ Vaccine System to Administer Flu Vaccine VaxiPatch ™ microneedle dermal patch is part of a novel vaccination system comprised of subunit antigens and adjuvants Preclinical data use of VaxiPatch™ microneedle dermal patch with proprietary vaccine showed significantly higher immune response at much smaller dose compared with an existing influenza vacci

Demand for chromatography data systems in various research and laboratory operations has risen exponentially in last two decades owing to the benefits such as smooth and hassle-free laboratory operations.

OKYO, the life sciences and biotechnology company, focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and chronic pain, is pleased to announce that that Dr. Napoleone Ferrara, MD, Professor at the University of California San Diego Medical Center, has agreed to serve on its scientific advisory board.

Dr. Reddy’s Laboratories Ltd. announced the launch of AVIGAN® 200 mg Tablets in India.